FDARulemakingFDA-2011-N-0898

Who commented on this docket

Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance

8 organizations filed 8 public comments on Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance, at the Food and Drug Administration. The comment window closed 4589d ago.

Organizations
8
Comments
8
RIN
Comment window
closed 4589d ago

Commenters (8)

  • American Academy of Pediatrics (AAP)
    1 filing · confidence 97%
  • American Hospital Association AHAtrade assoc.
    1 filing · confidence 85%
  • American Society of Health-System Pharmaciststrade assoc.
    1 filing · confidence 85%
  • American Society of Hematologytrade assoc.
    1 filing · confidence 85%
  • Colon Cancer Alliancetrade assoc.
    1 filing · confidence 85%
  • Pfizer Inc.unverified attribution
    1 filing · confidence 70%
  • the American Dental Association and the American Association of Oral and Maxillofacial Surgeonstrade assoc.
    1 filing · confidence 85%
View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.